Nasal Drug Delivery Market Size (2022-2030) Share, Industry

Nasal Drug Delivery Market Size (2022-2030) Share, Industry

Pune, Oct 27, 2022 (GLOBE NEWSWIRE) — According to the latest report published by Growth Plus Reports, the nasal drug delivery market the clock is expected US$108.33 billion by 2030 and grow in a CAGR of 6.1% during the forecast period. This exclusive information is published by Growth Plus Reports in its report titled “Nasal Medication Delivery Market: Global Outlook and Forecast 2022-2030”

The Nasal Medication Delivery System delivers local and systemic medications using the nasal cavity (nose) as the route of administration. This type of medication delivery system offers numerous benefits, including quick impact and a hands-on approach. Due to the faster absorption of the drug through the high permeability of the nasal epithelium, which avoids hepatic and membrane first-pass metabolism, it is an alternative option for the oral drug delivery system.

Download PDF Brochure of Nasal Drug Delivery Market Size – COVID-19 Impact and Global Analysis with Strategic Developments on: https://growthplusreports.com/inquiry/request-sample/nasal-drug-delivery-market/7901

market indicators

The nasal drug delivery market is quite large and is anticipated to develop steadily over the forecast period. The market is expanding due to the increased incidence of COPD (chronic obstructive pulmonary disease) and asthma, changing patient preferences, and growing public demand for nasal drug delivery systems. The development of technical improvements such as intelligent nasal drug delivery systems, increased consumption of self-administered drugs, and high accessibility all contribute to the rise of the market. In addition, increased R&D activities and improved focus on nasal drug delivery system designs are also contributing to market growth.

The nasal drug delivery market has been analyzed from four perspectives: type, application, distribution channel, and region.

Excerpts from ‘Segmentation by type’

Types in the nasal drug delivery market have been divided into:

  • nebulizers
  • metered dose inhalers
  • dry powder inhalers

Dry powder inhalers generate the majority of the market revenue. The stability of the product, the ability to provide low or high doses as needed and its low sensitivity to microbes are some of the aspects that can be attributed to the rise of the segment. Metered dose inhalers also have a considerable position in the market. The benefits of metered-dose inhalers, such as the ability to deliver multiple doses, reduced dose/drug loss, and convenience of use, support the continuing demand for metered-dose inhalers. In addition, it provides a restricted and determined amount of drug, can be used for pressurized metered dosages, and does not require the prior preparation of pharmaceuticals.

Excerpts from ‘Segmentation by region’

The global nasal drug delivery market has been segmented into:

  • North America
  • Europe
  • Pacific Asia
  • Rest of the world

North America has the largest revenue share in the market. The existence of state-of-the-art technology, a developed health infrastructure and an increase in R&D activities contribute to the development of the market. In addition, the increase in respiratory illnesses, the use of nasal drug delivery systems, and an increase in nasal vaccination procedures. Due to the increasing incidence of infections, asthma, etc., Europe ranks second in revenue share. Asia Pacific is a developing regional market due to a growing elderly population, expanding healthcare infrastructure, rising vaccination rates, and many other factors. The demand for nasal drug delivery is also developing due to increasing R&D activity and rising healthcare spending.

Talk to our analyst to understand the impact of COVID-19 on your business: https://growthplusreports.com/inquiry/speak-analyst/nasal-drug-delivery-market/7901

Excerpts from ‘Competitive Landscape’

Some prominent players operating in the nasal drug delivery market are

  • gofire inc.
  • 3M company
  • Teva Pharmaceutical Industries Ltd.
  • Nemera France S.A.S.
  • AptarGroup Inc.
  • H&T Presspart Manufacturing Ltd.
  • Consort Medical Plc.
  • Vectura Group Limited
  • Merck & Co Inc.
  • johnson & johnson services inc.
  • GSK plc.
  • pfizer inc.

Table of Contents

  1. INTRODUCTION
    1. market ecosystem
    2. Timeline under consideration
      1. Historical Years – 2020
      2. Base Year – 2021
      3. Projected years: 2022 to 2030
    3. Currency used in the report
  2. RESEARCH METHODOLOGY
    1. Research focus
    2. Data collection methodology
    3. data sources
      1. secondary sources
      2. primary sources
    4. Market estimation approach
      1. Bottom up
      2. From top to bottom
    5. Market forecast model
    6. Limitations and assumptions
  3. PREMIUM OUTLOOK
    1. Current market trends (COVID-19 perspective)
    2. Key players and competitive positioning (2021)
  4. MARKET DYNAMICS
    1. drivers
    2. restrictions
    3. Opportunities
  5. GLOBAL NASAL DRUG DELIVERY MARKET: ANALYSIS AND FORECAST, BY TYPE
    1. nebulizer
    2. metered dose inhaler
    3. dry powder inhaler
  6. GLOBAL NASAL DRUG DELIVERY MARKET: ANALYSIS AND FORECAST, BY APPLICATION
    1. Asthma
    2. Chronic Obstructive Pulmonary Disease (COPD)
    3. Nasal congestion
    4. Rhinitis
    5. Vaccination
  7. GLOBAL NASAL DRUG DELIVERY MARKET: ANALYSIS AND FORECAST, BY DISTRIBUTION CHANNEL
    1. Hospitals and Clinics
    2. Retail Pharmacies
    3. online pharmacies

OCD Continues…

VALUE PROPOSALS RELATED TO THE REPORT:

  • Powered by complimentary analyst hours and expert interviews with every report
  • Comprehensive quantitative and qualitative insights at the segment and sub-segment level
  • Covid 19 impact trends and outlook
  • Granular insights at the global/regional/country level
  • Deep insights into market dynamics (drivers, constraints, opportunities) and the business environment
  • General coverage of the competitive landscape
  • win imperatives
  • Comprehensive coverage on ‘Strategic Developments’ recorded by major market players

CUSTOMIZATION OPTIONS:

  • Dealer Landscape Assessment
  • price intelligence
  • Evaluation of the customer base
  • Analysis of Investments and Initiatives
  • ‘Business profile’ of key players

Directly buy a premium copy of Nasal Drug Delivery Market Growth Report (2022-2030) at: https://growthplusreports.com/checkout?_token=JnROTnndiKLZbUHJuPGma1iwEjDenDTp62AJJgqE&report_id=7901&license=Single

About us:

Growth Plus Reports is part of GRG Health, a global healthcare insights services company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).

Growth Plus’ portfolio of services builds on our core capabilities of secondary and primary research, market modeling and forecasting, benchmarking, analysis and strategy formulation to help clients create scalable and innovative solutions that prepare them for growth. and future success.

We were awarded by the prestigious CEO Magazine as “The most innovative healthcare market research company in 2020.


        

Leave a Comment